Parmar, Mahesh KB

Abiraterone for prostate cancer not previously treated with hormone therapy

James, N. D., de Bono, J. S., Spears, M. R., Clarke, N. W., Mason, M. D., Dearnaley, D. P., Ritchie, A. W. S., Amos, C. L., Gilson, C., Jones, R. J., et al. (2017) · New England Journal of Medicine

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 1,801

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Jacobs, I. J., Menon, U., Ryan, A., Gentry-Maharaj, A., Burnell, M., Kalsi, J. K., Amso, N. N., Apostolidou, S., Benjamin, E., Cruickshank, D., et al. (2016) · The Lancet

Ovarian cancer diagnosis and treatmentGlobal Cancer Incidence and Screening

Cited by 1,048

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Menon, U., Gentry-Maharaj, A., Burnell, M., Singh, N., Ryan, A., Karpinskyj, C., Carlino, G., Taylor, J., Massingham, S. K., Raikou, M., et al. (2021) · The Lancet

Ovarian cancer diagnosis and treatmentGlobal Cancer Incidence and Screening

Cited by 730

Bayesian approaches to randomized trials

Spiegelhalter, D. J., Freedman, L. S., & Parmar, M. K. B. (1994) · Journal of the Royal Statistical Society. Series A (Statistics in Society)

Statistical Methods in Clinical TrialsStatistical Methods and Bayesian Inference

Cited by 720

The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer

Smith, J. C., Bennett, S., Evans, L. M., Kynaston, H. G., Parmar, M., Mason, M. D., Cockcroft, J. R., Scanlon, M. F., & Davies, J. S. (2001) · The Journal of Clinical Endocrinology & Metabolism

Cardiovascular Health and Disease PreventionHormonal and reproductive studies

Cited by 458

Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis

Field, J. K., Vulkan, D., Davies, M. P. A., Baldwin, D. R., Brain, K. E., Devaraj, A., Eisen, T., Gosney, J., Green, B. A., Holemans, J. A., et al. (2021) · The Lancet Regional Health - Europe

Lung Cancer Diagnosis and TreatmentGlobal Cancer Incidence and Screening

Cited by 230

Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study

Menon, U., Gentry-Maharaj, A., Ryan, A., Sharma, A., Burnell, M., Hallett, R., Lewis, S., Lopez, A., Godfrey, K., Oram, D., et al. (2008) · BMJ

Ethics in Clinical ResearchHealth Policy Implementation Science

Cited by 151

More multiarm randomised trials of superiority are needed

Parmar, M. K. B., Carpenter, J., & Sydes, M. R. (2014) · The Lancet

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 127

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial

James, N. D., Sydes, M. R., Mason, M. D., Clarke, N. W., Anderson, J., Dearnaley, D. P., Dwyer, J., Jovic, G., Ritchie, A. W., Russell, J. M., et al. (2012) · The Lancet Oncology

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 123

Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials

Sydes, M. R., Spiegelhalter, D. J., Altman, D. G., Babiker, A. B., Parmar, M. K., & DAMOCLES Group (2004) · Clinical Trials

Statistical Methods in Clinical TrialsEthics in Clinical Research

Cited by 76

Sharing data from clinical trials: The rationale for a controlled access approach

Sydes, M. R., Johnson, A. L., Meredith, S. K., Rauchenberger, M., South, A., & Parmar, M. K. (2015) · Trials

Research Data Management PracticesEthics in Clinical Research

Cited by 67

Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study

Sydes, M. R., Altman, D. G., Babikera, A. B., Parmar, M. K., Spiegelhalter, D. J., & DAMOCLES group (2004) · Clinical Trials

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 49

Discrimination-based sample size calculations for multivariable prognostic models for time-to-event data

Jinks, R. C., Royston, P., & Parmar, M. K. (2015) · BMC Medical Research Methodology

Statistical Methods in EpidemiologyStatistical Methods in Clinical Trials

Cited by 32

A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials.

Tierney, J. F., Fisher, D. J., Vale, C. L., Burdett, S., Rydzewska, L. H., Rogozińska, E., Godolphin, P. J., White, I. R., & Parmar, M. K. B. (2021) · PLOS Medicine

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 31